Cravath’s New York Office Moves to Two Manhattan West
March 31, 2023
On March 30, 2023, Cravath partner J. Leonard Teti II participated in the 23rd Annual U.S. and Europe Tax Practice Trends Conference, which was held March 29‑31, 2023 in Zurich, Switzerland and presented by the International Bar Association Taxes Committee, American Bar Association Tax Section and USA Branch of the International Fiscal Association. Len co‑chaired the panel entitled “Is My Footprint Big Enough? Implementing ATAD 3 – Substance Requirements and Impact on Transatlantic Investment Structures,” which discussed case studies related to the proposed Anti‑Tax Avoidance Directive 3 of the European Commission.
Deals & Cases
March 06, 2023
On March 6, 2023, LexisNexis® Risk Solutions, part of RELX, a global provider of information‑based analytics and decision tools for professional and business customers, announced it has entered into a definitive agreement to acquire Human API, a leading provider of consumer‑driven health data to life insurance and healthcare customers. Cravath is representing RELX in connection with the transaction.
Deals & Cases
February 09, 2023
On February 8, 2023, IBM announced the acquisition of StepZen Inc, which developed a GraphQL server with a unique architecture that helps developers build GraphQL APIs quickly and with less code. Cravath is representing IBM in connection with the transaction.
Deals & Cases
February 02, 2023
On February 2, 2023, FS Investments, a pioneer in the democratization of alternative investments with more than $35 billion in assets under management, and Portfolio Advisors, a global middle‑market private asset specialist with more than $38 billion in assets under management, announced they have entered into a definitive agreement to combine their firms. The combined company will be poised for growth with over $73 billion in assets under management, including a significant permanent capital base, and a robust distribution platform. Cravath is representing FS Investments in connection with the transaction.
Deals & Cases
February 01, 2023
Cravath represented Monogram Health Holdings, Inc. in connection with its $375 million Series C financing round, consisting of a private placement of series C preferred stock. Monogram Health Holdings is the parent company of Monogram Health, Inc., a leading kidney‑disease‑focused benefit management and care delivery company. The transaction closed on December 23, 2022.
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. ©2024 Cravath, Swaine & Moore LLP.